BioSpace News Archive

Biotech Bay

XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock

XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced an underwritten registered public offering of shares of its Series A Cumulative Perpetual Preferred Stock, with liquidation preference of $25.00 per share (the “Preferred Stock”).

December 10, 2020
·
4 min read
Bruise Treatment Market: Rising prevalence of blood disorders to drive the market

A bruise is a skin injury that results in discoloration of the skin. Bruises are more common in patients taking medication for thinning their blood.

December 10, 2020
·
4 min read
New Study Associates Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, as Part of Pediatric Patient Blood Management, with Reduced ICU Stays and Postoperative Transfusion

Masimo announced the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Saraçoğlu and colleagues at Marmara University in Istanbul, Turkey investigated the efficacy of Masimo noninvasive and continuous hemoglobin monitoring, SpHb®, as part of the transfusion management of pediatric patients undergoing major surgery.

December 10, 2020
·
10 min read
Biotech API Manufacturing Services Market: Adherence to CDER Standards Helps in Production of High-quality Drugs

Drug ingredient trade shows, such as the CPhl Worldwide, have been experiencing a monotony in product offerings.

December 10, 2020
·
4 min read
IRRAS Announces Expansion of IRRAflow Launch to Latin America

Finalization of agreement with distribution partner in Argentina allows access into initial Latin American markets

December 10, 2020
·
2 min read
Drug Development

Apellis and Sobi Report Positive Top-line Results at 48 Weeks from the Phase 3 PEGASUS Study of Pegcetacoplan in PNH

Treatment with pegcetacoplan resulted in a sustained improvement in hemoglobin with a mean increasefrom baseline of 2.7g/dLat Week 48, which isequal tothe2.7 g/dL increaseseen at Week 16 with pegcetacoplan-treated patients

December 10, 2020
·
9 min read
Biotech Beach

Decentralized Trials & Research Alliance (DTRA) Launches to Democratize and Accelerate Clinical Trials

A historic alliance of life sciences and healthcare organizations seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.

December 10, 2020
·
2 min read
BioMidwest

USA Equities Corp. (USAQ) and AllergiEnd Announces Allergy Testing Kit Distribution ahead of COVID-19 Vaccine

While the recent and rapid development of Pfizer/BioNTech’s COVID-19 vaccine is undoubtedly good news, Time Magazine reported that administering this vaccine to individuals with a history of severe allergic reactions is not recommended, according to a U.K.

December 10, 2020
·
4 min read
Drug Development

ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures

ASPIVIX SA, a developer of medical technologies to advance gynecological care, today announced completion of and interim analysis results from its Phase I first-in-women trial.

December 10, 2020
·
2 min read
Drug Development

First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma

Novocure (NASDAQ: NVCR) today announced the first patient has been enrolled in its global phase 3 TRIDENT trial, a randomized study in newly diagnosed glioblastoma (GBM) testing the potential survival benefit of initiating Optune concurrent with radiation therapy

December 10, 2020
·
6 min read